Cargando…

The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease

Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunxian, Zhou, Xiwen, Chen, Zhixin, Xia, Jue, Guan, Fenglei, Li, Yue, Li, Yanrong, Chen, Yicai, Zhao, Yuanlin, Qiu, Huayun, Liang, Jiarong, Tang, Liangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246482/
https://www.ncbi.nlm.nih.gov/pubmed/37278148
http://dx.doi.org/10.1080/0886022X.2023.2220420
_version_ 1785055038754783232
author Chen, Yunxian
Zhou, Xiwen
Chen, Zhixin
Xia, Jue
Guan, Fenglei
Li, Yue
Li, Yanrong
Chen, Yicai
Zhao, Yuanlin
Qiu, Huayun
Liang, Jiarong
Tang, Liangqiu
author_facet Chen, Yunxian
Zhou, Xiwen
Chen, Zhixin
Xia, Jue
Guan, Fenglei
Li, Yue
Li, Yanrong
Chen, Yicai
Zhao, Yuanlin
Qiu, Huayun
Liang, Jiarong
Tang, Liangqiu
author_sort Chen, Yunxian
collection PubMed
description Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking.Methods: We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve.Results: The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789–0.894) and 0.821 (95% CI: 0.760–0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03–9.86; p = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54–14.68; p = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02–8.24; p = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66–16.86, p = 0.005).Conclusions: Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD.
format Online
Article
Text
id pubmed-10246482
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-102464822023-06-08 The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease Chen, Yunxian Zhou, Xiwen Chen, Zhixin Xia, Jue Guan, Fenglei Li, Yue Li, Yanrong Chen, Yicai Zhao, Yuanlin Qiu, Huayun Liang, Jiarong Tang, Liangqiu Ren Fail Research Article Background: High-sensitivity cardiac troponin T (hs-cTnT) and creatine kinase (CK)-MB are the most commonly used biomarkers for the diagnosis and prognosis of acute myocardial infarction (AMI). Chronic kidney disease (CKD) often leads to elevated hs-cTnT levels in non-AMI patients. However, studies comparing the prognostic value of both hs-cTnT and CK-MB in patients with AMI and CKD are lacking.Methods: We conducted a retrospective study on AMI patients diagnosed between January 2015 and October 2020. Patients were categorized based on renal function as normal or CKD. Peak hs-cTnT and CK-MB levels during hospitalization were collected, and their diagnostic value was evaluated using receiver operating characteristic (ROC) curves. The impact on in-hospital mortality was analyzed using multivariate logistic regression. The relationship between the hs-cTnT/CK-MB ratio and in-hospital death was examined using a restricted cubic spline (RCS) curve.Results: The study included 5022 AMI patients, of whom 797 (15.9%) had CKD. The AUCs of Hs-cTnT and CK-MB were higher in the CKD group [0.842 (95% CI: 0.789–0.894) and 0.821 (95% CI: 0.760–0.882)] than in the normal renal function group [0.695 (95% CI: 0.604-0.790) and 0.708 (95% CI: 0.624-0.793)]. After full adjustment for all risk factors, hs-cTnT (OR, 2.82; 95% CI, 1.03–9.86; p = 0.038) and CK-MB (OR, 4.91; 95% CI, 1.54–14.68; p = 0.007) above the cutoff values were independent predictors of in-hospital mortality in patients with CKD. However, in patients with normal renal function, only CK-MB above the cutoff (OR, 2.45; 95% CI, 1.02–8.24; p = 0.046) was a predictor of in-hospital mortality, whereas hs-cTnT was not. There was an inverted V-shaped relationship between the hs-cTnT/CK-MB ratio and in-hospital mortality, with an inflection point of 19.61. The ratio within the second quartile (9.63-19.6) was an independent predictor of in-hospital mortality in patients with CKD (OR 5.3, 95% CI 1.66–16.86, p = 0.005).Conclusions: Hs-cTnT independently predicted in-hospital mortality in AMI patients with CKD, whereas its predictive value was not observed in patients with normal renal function. CK-MB was an independent predictor of in-hospital mortality regardless of renal function. Moreover, the hs-cTnT/CK-MB ratio may aid in risk stratification of AMI patients with CKD. Taylor & Francis 2023-06-06 /pmc/articles/PMC10246482/ /pubmed/37278148 http://dx.doi.org/10.1080/0886022X.2023.2220420 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Research Article
Chen, Yunxian
Zhou, Xiwen
Chen, Zhixin
Xia, Jue
Guan, Fenglei
Li, Yue
Li, Yanrong
Chen, Yicai
Zhao, Yuanlin
Qiu, Huayun
Liang, Jiarong
Tang, Liangqiu
The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title_full The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title_fullStr The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title_full_unstemmed The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title_short The use of high-sensitivity cardiac troponin T and creatinine kinase-MB as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
title_sort use of high-sensitivity cardiac troponin t and creatinine kinase-mb as a prognostic markers in patients with acute myocardial infarction and chronic kidney disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246482/
https://www.ncbi.nlm.nih.gov/pubmed/37278148
http://dx.doi.org/10.1080/0886022X.2023.2220420
work_keys_str_mv AT chenyunxian theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT zhouxiwen theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT chenzhixin theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT xiajue theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT guanfenglei theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liyue theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liyanrong theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT chenyicai theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT zhaoyuanlin theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT qiuhuayun theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liangjiarong theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT tangliangqiu theuseofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT chenyunxian useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT zhouxiwen useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT chenzhixin useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT xiajue useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT guanfenglei useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liyue useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liyanrong useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT chenyicai useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT zhaoyuanlin useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT qiuhuayun useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT liangjiarong useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease
AT tangliangqiu useofhighsensitivitycardiactroponintandcreatininekinasembasaprognosticmarkersinpatientswithacutemyocardialinfarctionandchronickidneydisease